These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6362058)

  • 21. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects of high dose aspirin on platelet adhesion to experimental autogenous vein grafts.
    Gershlick AH; Syndercombe Court YD; Murday AJ; Lewis CT; Mills PG
    Cardiovasc Res; 1985 Dec; 19(12):770-6. PubMed ID: 3910252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does non-acetylated salicylate inhibit thromboxane biosynthesis in human platelets?
    Danesh BJ; McLaren M; Russell RI; Lowe GD; Forbes CD
    Scott Med J; 1988 Aug; 33(4):315-6. PubMed ID: 3187504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acetylsalicylic acid and dietary intervention on primary hemostasis.
    Thorngren M; Gustafson A
    Am J Med; 1983 Jun; 74(6A):66-71. PubMed ID: 6344628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
    Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of acetylsalicyclic acid on platelet function.
    Evans G; Packham MA; Nishizawa EE; Mustard JF; Murphy EA
    J Exp Med; 1968 Nov; 128(5):877-94. PubMed ID: 4176225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salicylate antagonism of acetylsalicylic acid inhibition of platelet aggregation in male and female subjects: influence of citrate concentration.
    Philp RB; Paul ML
    Haemostasis; 1986; 16(5):369-77. PubMed ID: 3096843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
    Brassard JA; Meyers KM
    Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats, rabbits, and guinea pigs correlate negatively with the vascular PGI2 production.
    Tschopp TB; Baumgartner HR
    J Lab Clin Med; 1981 Sep; 98(3):402-11. PubMed ID: 7021720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of effects of aspirin on platelet function in healthy volunteers: an analysis using the PFA-100.
    Konrad CJ; Schuepfer GK; Gerber H; Rukwied R; Schmelz M; Schley M
    J Clin Anesth; 2006 Feb; 18(1):12-7. PubMed ID: 16517326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.
    Watala C; Pluta J; Golanski J; Rozalski M; Czyz M; Trojanowski Z; Drzewoski J
    J Mol Med (Berl); 2005 Feb; 83(2):148-58. PubMed ID: 15723265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Mouse Model for Studying Hemostatic Function of Human Platelets.
    Paul DS; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1891-1904. PubMed ID: 32493172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects.
    Buchanan MR; Rischke JA; Butt R; Turpie AG; Hirsh J; Rosenfeld J
    Thromb Res; 1983 Jan; 29(2):125-39. PubMed ID: 6221436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of salicylate on platelets and whole blood adenine nucleotides.
    Davies DT; Hughes A; Tonks RS
    Br J Pharmacol; 1969 Jul; 36(3):437-47. PubMed ID: 5789804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.
    Louie S; Gurewich V
    Thromb Res; 1983 May; 30(4):323-35. PubMed ID: 6351340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
    Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
    J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.